How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Automate the process of grouping thousands of search queries into coherent topics for faster, more scalable content planning.
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Zoom out. What’s this place all about? There's finally new life at the Franklin School, the beautiful, long-neglected circa-1869 brick building in downtown Washington. Pass under a whispering ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Copyright 2026 The Denver Post. All rights reserved. The use of any content on this website for the purpose of training artificial intelligence systems, algorithms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results